Catalyst Wire Dossier Catalyst Wire Dossier

Lagricel Ofteno

· Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lagricel Ofteno, covering 2021-05-03 to 2021-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution [Phase 1]

See pricing